Commissioning of MRI-only based treatment planning procedure for external beam radiotherapy of prostate

Magnetic Resonance in Medicine

Volumn 70, Issue 1, 2013, Pages 127-135

  Kapanen, Mika ^a   Collan, Juhani ^a   Beule, Annette ^a   Seppälä, Tiina ^a   Saarilahti, Kauko ^a   Tenhunen, Mikko ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

computed tomography substitute; gold seeds; image distortion; magnetic resonance imaging; prostate; radiotherapy planning

Indexed keywords

COMPUTERIZED TOMOGRAPHY; DISEASES; GEOMETRY; GOLD; IONIZING RADIATION; MAGNETIC RESONANCE IMAGING; MAGNETISM; QUALITY ASSURANCE; QUALITY CONTROL; RESONANCE; SYSTEMATIC ERRORS; TISSUE; UROLOGY;

COMPUTED TOMOGRAPHY IMAGES; EXTERNAL BEAM RADIOTHERAPY; EXTERNAL RADIOTHERAPY; GOLD SEEDS; IMAGE DISTORTIONS; PROSTATE; QUALITY ASSURANCE TESTING; RADIOTHERAPY PLANNING;

RADIOTHERAPY;

ARTICLE; EXTERNAL BEAM RADIOTHERAPY; IMAGE ANALYSIS; IONIZING RADIATION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PHANTOM; PROSTATE CANCER; QUALITY CONTROL; QUANTITATIVE ANALYSIS; RADIOSENSITIVITY; RECTUM; TREATMENT PLANNING; VIRTUAL REALITY;

EID: 84879409527     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.24459     Document Type: Article

References (21)

1. Lee YK, Bollet M, Charles-Edwards G, Flower MA, Leach MO, McNair H, Moore E, Rowbottom C, Webb S,. Radiotherapy treatment planning of prostate cancer using magnetic resonance imaging alone. Radiother Oncol 2003; 66: 203-216.
2. Chen L, Price RA, Wang L, Jinsheng L, Qin L, McNeeley S, Ma C, Freedman GM, Pollack A,. MRI-based treatment planning for radiotherapy: dosimetric verification for prostate IMRT. Int J Radiat Oncol Biol Phys 2004; 60: 636-647.
3. Jonsson JH, Karlsson MG, Karlsson M, Nyholm T,. Treatment planning using MRI data: an analysis of the dose calculation accuracy for different treatment regions. Radiat Oncol 2010; 5: 62-69.
4. Lambert J, Greer PB, Menk F, et al. MRI-guided prostate radiation therapy planning: investigation of dosimetric accuracy of MRI-based dose planning. Radiother Oncol 2011; 98: 330-334.
5. Roberson P, McLaughlin P, Narayana V, Troyer S, Hixson GV, Kessler ML,. Use and uncertainties of mutual information for computed tomography/magnetic resonance (CT/MR) registration post permanent implant of the prostate. Med Phys 2005; 32: 473-482.
6. Nyholm T, Nyberg M, Karlsson MG, Karlsson M,. Systematisation of spatial uncertainties for comparison between a MR and a CT-based radiotherapy workflow for prostate treatments. Radiat Oncol 2009; 4: 54-62.
7. Fransson A, Andreo P, Pötter R,. Aspects of MR image distortions in radiotherapy treatment planning. Strahlenther Onkol 2001; 177: 59-73.
8. Karlsson M, Karlsson MG, Nyholm T, Amies C, Zackrisson B,. Dedicated magnetic resonance imaging in the radiotherapy clinic. Int J Radiat Oncol Biol Phys 2009; 74: 644-651.
9. Parker C, Damyanovich A, Haycocks T, Haider M, Bayley A, Catton CN,. Magnetic resonance imaging in the radiation treatment planning of localized prostate cancer using intra-prostatic fiducial markers for computed tomography co-registration. Radiother Oncol 2003; 66: 217-224.
10. Huisman H, Fütterer JJ, Van Lin EN, Welmers A, Scheenen TW, van Dalen JA, Visser AG, Witjes JA, Barentsz JO,. Prostate cancer: precision of integrating functional MR imaging with radiation therapy treatment by using fiducial gold markers. Radiology 2005; 236: 311-317.
11. Seevinck PR, de Leeuw H, Bos C, Bakker CJG,. Highly localized positive contrast of small paramagnetic objects using 3D center-out radial sampling with off-resonance reception. Magn Reson Med 2011; 65: 146-156.
12. Bos C, Viergever MA, Bakker CJ,. On the artifact of a subvoxel susceptibility deviation in spoiled gradient-echo imaging. Magn Reson Med 2003; 50: 400-404.
13. McJury M, O'Neill A, Lawson M, McGrath C, Grey A, Page W, O'Sullivan JM,. Assessing the image quality of pelvic MR images acquired with a flat couch for radiotherapy treatment planning. Br J Radiol 2011; 84: 750-755.
14. American College of Radiology (ACR). Phantom test guidance for the ACR MRI accreditation program. Reston, VA: ACR; 2005.
15. Kapanen M, Tenhunen M,. T1/T2*-weighted MRI provides clinically relevant pseudo-CT density data for the pelvic bones in MRI-only based radiotherapy treatment planning. Acta Oncol 2012. doi: 10.3109/0284186X.2012. 692883.
16. Chen L, Nguyen TB, Jones E, Chen Z, Luo W, Wang L, Price RA, Pollack A, Ma C,. Magnetic resonance-based treatment planning for prostate intensity-modulated radiotherapy: creation of digitally reconstructed radiographs. Int J Radiat Oncol Biol Phys 2007; 68: 903-911.
17. Pasquier D, Lacornerie T, Vermandel M, Rousseau J, Lartigau E, Betrouni N,. Automatic segmentation of pelvic structures from magnetic resonance images for prostate cancer radiotherapy. Int J Rad Oncol Biol Phys 2007; 68: 592-600.
18. Dowling JA, Lambert J, Parker J, Salvado O, Fripp J, Capp A, Wratten C, Denham JW, Greer PB,. An atlas-based electron density mapping method for magnetic resonance imaging (MRI)-alone treatment planning and adaptive MRI-based prostate radiation therapy. Int J Radiat Oncol Biol Phys 2012; 83: e5-e11.
19. Mutic S, Palta JR, Butker EK, Das IJ, Huq MS, Dick Loo LN, Salter BJ, McCollough CH, Van Dyk JV,. Quality assurance for computed-tomography simulators and the computed-tomography-simulation process: report of the AAPM radiation therapy committee task group no. 66. Med Phys 2003; 30: 2762-2792.
20. Schenck JF,. The role of magnetic susceptibility in magnetic resonance imaging: MRI magnetic compatibility of the first and second kinds. Med Phys 1996; 23: 815-850.
21. Van der Put RW, Raaymakers BW, Kerkhof EM, van Vulpen M, Lagendijk JJW,. A novel method for comparing 3D target volume delineations in radiotherapy. Phys Med Biol 2008; 53: 2149-2159.